Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,526.80
(
0.55%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
107.07
(
-1.93%
)
Bitcoin
69,828.25
(
1.19%
)
News Focus
News Focus
Post# of 257364
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122852
Boards Moderated 8
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 256476

Thursday, 11/20/2025 2:32:54 PM

Thursday, November 20, 2025 2:32:54 PM

Post# of 257364
ABT CEO response to CC question on competition to Cologuard from blood tests was weak and incomplete, IMO. He should have said that, scientifically, it's all but impossible for a blood test to match the sensitivity/specificity of a stool-based test for detecting colorectal cancer.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now